Search research articles
Contact Us
Filters
Showing results (91-100 of 111) with videos related to
Page
of 12
Sort By:
Trials
|
November 9, 2022
Intensified tuberculosis treatment to reduce the mortality of HIV-infected and uninfected patients with tuberculosis meningitis (INTENSE-TBM): study protocol for a phase III randomized controlled trial
Thomas Maitre, Maryline Bonnet, Alexandra Calmy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 21, 2021
Effectiveness and Cardiac Safety of Bedaquiline-Based Therapy for Drug-Resistant Tuberculosis: A Prospective Cohort Study
James C M Brust, Neel R Gandhi, Sean Wasserman, et al.
Southern African Journal of Infectious Diseases
|
January 15, 2024
Changing character and waning impact of COVID-19 at a tertiary centre in Cape Town, South Africa
Lucas E Hermans, Petro Booysen, Linda Boloko, et al.
Gates Open Research
|
November 23, 2023
Higher mortality associated with the SARS-CoV-2 Delta variant in the Western Cape, South Africa, using RdRp target delay as a proxy: a cross-sectional study
Hannah Hussey, Mary-Ann Davies, Alexa Heekes, et al.
Nature Communications
|
January 12, 2023
Effects of tuberculosis and/or HIV-1 infection on COVID-19 presentation and immune response in Africa
Elsa du Bruyn, Cari Stek, Remi Daroowala, et al.
Eclinicalmedicine
|
October 12, 2020
The utility of high-flow nasal oxygen for severe COVID-19 pneumonia in a resource-constrained setting: A multi-centre prospective observational study
Gregory L Calligaro, Usha Lalla, Gordon Audley, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
March 2, 2022
Assessing the clinical severity of the Omicron variant in the Western Cape Province, South Africa, using the diagnostic PCR proxy marker of RdRp target delay to distinguish between Omicron and Delta infections - a survival analysis
Hannah Hussey, Mary-Ann Davies, Alexa Heekes, et al.
Scientific Reports
|
February 16, 2022
Convalescent plasma in the treatment of moderate to severe COVID-19 pneumonia: a randomized controlled trial (PROTECT-Patient Trial)
Karin van den Berg, Tanya Nadia Glatt, Marion Vermeulen, et al.
The Lancet. Respiratory Medicine
|
October 13, 2022
Colchicine and the combination of rivaroxaban and aspirin in patients hospitalised with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial
John W Eikelboom, Sanjit S Jolly, Emilie P Belley-Cote, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 9, 2022
A Phase 2A Trial of the Safety and Tolerability of Increased Dose Rifampicin and Adjunctive Linezolid, With or Without Aspirin, for Human Immunodeficiency Virus-Associated Tuberculous Meningitis: The LASER-TBM Trial
Angharad G Davis, Sean Wasserman, Cari Stek, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 111) with videos related to
Sort By:
Page
of 12
Trials
|
November 9, 2022
Intensified tuberculosis treatment to reduce the mortality of HIV-infected and uninfected patients with tuberculosis meningitis (INTENSE-TBM): study protocol for a phase III randomized controlled trial
Thomas Maitre, Maryline Bonnet, Alexandra Calmy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 21, 2021
Effectiveness and Cardiac Safety of Bedaquiline-Based Therapy for Drug-Resistant Tuberculosis: A Prospective Cohort Study
James C M Brust, Neel R Gandhi, Sean Wasserman, et al.
Southern African Journal of Infectious Diseases
|
January 15, 2024
Changing character and waning impact of COVID-19 at a tertiary centre in Cape Town, South Africa
Lucas E Hermans, Petro Booysen, Linda Boloko, et al.
Gates Open Research
|
November 23, 2023
Higher mortality associated with the SARS-CoV-2 Delta variant in the Western Cape, South Africa, using RdRp target delay as a proxy: a cross-sectional study
Hannah Hussey, Mary-Ann Davies, Alexa Heekes, et al.
Nature Communications
|
January 12, 2023
Effects of tuberculosis and/or HIV-1 infection on COVID-19 presentation and immune response in Africa
Elsa du Bruyn, Cari Stek, Remi Daroowala, et al.
Eclinicalmedicine
|
October 12, 2020
The utility of high-flow nasal oxygen for severe COVID-19 pneumonia in a resource-constrained setting: A multi-centre prospective observational study
Gregory L Calligaro, Usha Lalla, Gordon Audley, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
March 2, 2022
Assessing the clinical severity of the Omicron variant in the Western Cape Province, South Africa, using the diagnostic PCR proxy marker of RdRp target delay to distinguish between Omicron and Delta infections - a survival analysis
Hannah Hussey, Mary-Ann Davies, Alexa Heekes, et al.
Scientific Reports
|
February 16, 2022
Convalescent plasma in the treatment of moderate to severe COVID-19 pneumonia: a randomized controlled trial (PROTECT-Patient Trial)
Karin van den Berg, Tanya Nadia Glatt, Marion Vermeulen, et al.
The Lancet. Respiratory Medicine
|
October 13, 2022
Colchicine and the combination of rivaroxaban and aspirin in patients hospitalised with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial
John W Eikelboom, Sanjit S Jolly, Emilie P Belley-Cote, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 9, 2022
A Phase 2A Trial of the Safety and Tolerability of Increased Dose Rifampicin and Adjunctive Linezolid, With or Without Aspirin, for Human Immunodeficiency Virus-Associated Tuberculous Meningitis: The LASER-TBM Trial
Angharad G Davis, Sean Wasserman, Cari Stek, et al.
Page
of 12